Beam
Viraj Ichhaporia currently serves as Associate Director and Group Leader in Cell Biology at Beam Therapeutics, following a role as Senior Scientist in the same field. Their previous experience includes positions as Associate Principal Scientist at KSQ Therapeutics, where advancements in CRISPR/Cas9-engineered Tregs were achieved, and Scientist at EMD Serono, leading RNA-targeting small molecule strategies for autoimmune inflammatory diseases. Viraj gained fundamental research insights as a Ph.D. candidate at St. Jude Children's Research Hospital, focusing on tumor cell biology and the role of Sil1 in Marinesco-Sjögren Syndrome, and also contributed to various research initiatives during internships at Pfizer and other academic institutions. Educational credentials include a Ph.D. in Biomedical Sciences from The University of Tennessee Health Science Center and a certificate in Management Essentials from Harvard Business School Online.